BioSpace News Archive

Business

Med Center Health Formalizes Partnership With Omnicell to Drive Efficiency With Automated Medication Management

Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced that Med Center Health has signed a sole source agreement to partner with Omnicell to streamline and secure its medication management process

October 21, 2019
·
3 min read
Drug Development

STELARA® (ustekinumab) Data Demonstrate Long-Term Efficacy and Safety Results in Adults with Moderately to Severely Active Ulcerative Colitis in Phase 3 Extension Trial

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new two-year data from the long-term extension of the Phase 3 UNIFI study. The data demonstrated that the majority of adult patients with moderately to severely active ulcerative colitis who achieved symptomatic remission1 with STELARA® (ustekinumab) were able to sustain remission through week 92.

October 21, 2019
·
14 min read
Drug Development

Amygdala Neurosciences Awarded $1.35 million NIH Grant to Conduct Long Term, Phase 3 Enabling, Toxicology Studies

ANS-6637, which is in Phase 2 clinical development, is a new chemical entity selective ALDH2 Inhibitor with a mechanism of action expected to prevent craving and relapse for patients being treated for substance use disorders.

October 21, 2019
·
2 min read
Genetown

Homology Medicines Presents Data from Investigational PKU and MLD Gene Therapy Programs that Demonstrate Preclinical Proof-of-Concept for Potential One-Time Therapies

Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today the presentation of preclinical data that support its investigational gene therapy programs for the treatment of metachromatic leukodystrophy (MLD) and phenylketonuria (PKU) at the American Society of Human Genetics (ASHG) 2019 Meeting.

October 21, 2019
·
7 min read
Deals

Spherix Issues Update to Shareholders - Oct. 21, 2019

Spherix Incorporated President and CEO, Anthony Hayes, released a letter to shareholders outlining the Company’s plans for its previously disclosed dividend distribution.

October 21, 2019
·
5 min read
Veritas Health Innovation Receives Funding to Accelerate Integration of Research into Practice

Veritas Health Innovation Ltd is pleased to announce that it has received grant funding of AU$2,000,000 to support its mission to bring research into practice faster than ever before.

October 21, 2019
·
5 min read
Deals

Verseau Launches with $50 Million to Develop First-in-Class Macrophage-Targeted Immunotherapies and Appoints George Golumbeski as Chairman of the Board

PSGL-1 identified as lead macrophage checkpoint modulator (MCM) program for development in cancer

October 21, 2019
·
4 min read
Deals

Sartorius Signs Agreement to Acquire Select Danaher Life Science Platform Businesses

Proposed transaction to include label-free biomolecular characterization (FortéBio), chromatography hardware and resins, and microcarriers (SoloHill) businesses

October 21, 2019
·
4 min read
Drug Development

Genentech’s Tecentriq in Combination With Avastin Increased Overall Survival and Progression-free Survival in People With Unresectable Hepatocellular Carcinoma

First Phase III cancer immunotherapy study to show an improvement in overall survival and progression-free survival for the treatment of the most common form of liver cancer

October 21, 2019
·
17 min read
Policy

Perflow Medical Receives CE Mark Approval of Novel Cascade™ Agile

Promising clinical data for Cascade Net published in the Journal of NeuroInterventional Surgery

October 21, 2019
·
3 min read